Geficure Tablet
Marketer
Curemart Pharma Pvt Ltd
Salt Composition
Gefitinib (250mg)
Overview Geficure Tablet
Geficure tablets treat advanced non-small cell lung cancer. This medication is prescribed for patients with metastatic disease, abnormal epidermal growth factor receptor (EGFR) genes, and no prior cancer therapy. Dosage should strictly follow your physician's instructions, continuing treatment for the duration they specify. Treatment length depends on individual response. Regular liver function monitoring may be recommended. Common side effects include nausea, diarrhea, dry skin, and appetite loss. Increased fluid intake may mitigate some side effects. Report any concerning or worsening side effects to your doctor immediately. Report mouth sores, vision changes, or respiratory problems without delay. Women should utilize effective contraception throughout treatment and for one month post-treatment to prevent pregnancy. Always disclose all other medications you are currently using to your doctor.
Uses of Geficure Tablet
Lung cancer (excluding small cell type)
Major Benefits of Geficure Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Geficure Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Geficure Tablet:
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Vomiting
- Weakness
- Weight loss
- Eating disorder
- Allergic reaction
How to use Geficure Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Geficure Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, although consistent timing is recommended.
How Geficure Tablet works:
Geficure tablets are an anti-neoplastic agent. Their mechanism of action involves inhibiting the activity of a defective protein responsible for triggering cancerous cell proliferation, thus hindering or retarding tumor growth.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol consumption while taking Geficure Tablet.
PregnancyCONSULT YOUR DOCTOR
Using Geficure Tablet during pregnancy is contraindicated due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Geficure Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects of Geficure Tablet.
KidneyCAUTION
Patients with severe kidney impairment should use Geficure Tablets cautiously, as dosage modification may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Using Geficure Tablet in patients with liver disease appears to pose minimal risk. Current evidence indicates dose modification may not be necessary, but physician consultation is recommended.
What if you forget to take Geficure Tablet :
Omit any missed Geficure Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Geficure Tablet
| Label | Value |
|---|---|
| Chemical Category | Quinazoline amines |
| Developing Habits | No. |
| Type of Therapy | Cancer Drugs |
3,018 People bought this recently